U.S. Biological Skin Substitutes Market Size & Outlook
Related Markets
U.S. biological skin substitutes market highlights
- The U.S. biological skin substitutes market generated a revenue of USD 118.8 million in 2023 and is expected to reach USD 216.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, human donor tissue-derived products was the largest revenue generating type in 2023.
- Human Donor Tissue-Derived Products is the most lucrative type segment registering the fastest growth during the forecast period.
Biological skin substitutes market data book summary
| Market revenue in 2023 | USD 118.8 million |
| Market revenue in 2030 | USD 216.3 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | Human donor tissue-derived products |
| Fastest growing segment | Human Donor Tissue-Derived Products |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
| Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.0% of the global biological skin substitutes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biological skin substitutes market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 216.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biological Skin Substitutes Market Scope
Biological Skin Substitutes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Tissue Regenix | View profile | 51-100 | York, York, United Kingdom, Europe | http://www.tissueregenix.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Organogenesis Holdings Inc Class A | View profile | 862 | 85 Dan Road, Canton, MA, United States, 02021 | https://www.organogenesis.com |
| MiMedx Group Inc | View profile | 895 | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 | https://www.mimedx.com |
| Essity AB Class B | View profile | 45900 | Klarabergsviadukten 63, PO Box 200, Stockholm, Sweden, SE-101 23 | https://www.essity.com |
| Vericel Corp | View profile | 314 | 64 Sidney Street, Cambridge, MA, United States, 02139 | https://www.vcel.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Integra Lifesciences Holdings Corp | View profile | 3946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | https://www.integralife.com |
| 3M Co | View profile | 85000 | 3M Center, St. Paul, MN, United States, 55144 | https://www.3m.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
U.S. biological skin substitutes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.92% in 2024. Horizon Databook has segmented the U.S. biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest market share of 86.54% in North America in 2023. Large medical device companies are outsourcing parts of their regulatory functions, such as report writing & publishing, clinical trial application services, product design, and product maintenance, to regulatory service providers, thereby contributing to the growth of the medical device outsourcing market in the U.S.
These companies are also increasingly inclined toward medical device outsourcing due to the requirement of high maintenance and efficient systems for the management of raw materials, which results in minimizing the overall setup costs.
Moreover, medical device outsourcing helps the company focus on core capabilities, the sharing of associated risks, and improved service delivery, which are pertinent to gaining competitive advantages.
Reasons to subscribe to U.S. biological skin substitutes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. biological skin substitutes market databook
-
Our clientele includes a mix of biological skin substitutes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. biological skin substitutes market size, by type, 2018-2030 (US$M)
U.S. Biological Skin Substitutes Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
